CircRNAs and cancer: biomarkers and master regulators E Arnaiz, C Sole, L Manterola, L Iparraguirre, D Otaegui, CH Lawrie Seminars in cancer biology 58, 90-99, 2019 | 372 | 2019 |
New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies E Larrea, C Sole, L Manterola, I Goicoechea, M Armesto, M Arestin, ... International journal of molecular sciences 17 (5), 627, 2016 | 282 | 2016 |
The circulating transcriptome as a source of cancer liquid biopsy biomarkers C Sole, E Arnaiz, L Manterola, D Otaegui, CH Lawrie Seminars in cancer biology 58, 100-108, 2019 | 117 | 2019 |
Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases D Martinez, A Valera, NS Perez, LFS Villegas, B Gonzalez-Farre, C Sole, ... The American journal of surgical pathology 37 (2), 272-281, 2013 | 73 | 2013 |
Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma D Soldini, A Valera, C Solé, J Palomero, V Amador, JI Martin-Subero, ... The American journal of surgical pathology 38 (1), 86-93, 2014 | 66 | 2014 |
The circulating transcriptome as a source of biomarkers for melanoma C Solé, D Tramonti, M Schramm, I Goicoechea, M Armesto, LI Hernandez, ... Cancers 11 (1), 70, 2019 | 47 | 2019 |
miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential C Solé, E Larrea, G Di Pinto, M Tellaetxe, CH Lawrie Cancer letters 405, 79-89, 2017 | 38 | 2017 |
MicroRNAs as biomarkers of B-cell lymphoma C Solé, E Arnaiz, CH Lawrie Biomarker Insights 13, 1177271918806840, 2018 | 36 | 2018 |
In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications B Gonzalez-Farre, J Rovira, D Martinez, A Valera, A Garcia-Herrera, ... Modern Pathology 27 (12), 1599-1611, 2014 | 28 | 2014 |
Noncoding RNA expression and targeted next-generation sequencing distinguish tubulocystic renal cell carcinoma (TC-RCC) from other renal neoplasms CH Lawrie, M Armesto, M Fernandez-Mercado, M Arestín, L Manterola, ... The Journal of Molecular Diagnostics 20 (1), 34-45, 2018 | 26 | 2018 |
MicroRNAs and metastasis C Solé, CH Lawrie Cancers 12 (1), 96, 2019 | 24 | 2019 |
Circular RNAs and cancer: Opportunities and challenges C Sole, CH Lawrie Advances in Clinical Chemistry 99, 87-146, 2020 | 21 | 2020 |
The use of circRNAs as biomarkers of cancer C Solé, G Mentxaka, CH Lawrie Long Non-Coding RNAs in Cancer, 307-341, 2021 | 20 | 2021 |
The urinary transcriptome as a source of biomarkers for prostate cancer C Solé, I Goicoechea, A Goñi, M Schramm, M Armesto, M Arestin, ... Cancers 12 (2), 513, 2020 | 20 | 2020 |
MicroRNAs in metastasis and the tumour microenvironment C Solé, CH Lawrie International Journal of Molecular Sciences 22 (9), 4859, 2021 | 19 | 2021 |
Circulating microRNAs as cancer biomarkers in liquid biopsies B Suárez, C Solé, M Márquez, F Nanetti, CH Lawrie Systems Biology of MicroRNAs in Cancer, 23-73, 2022 | 17 | 2022 |
Aberrant expression of MicroRNAs in B-cell lymphomas C Sole, E Larrea, L Manterola, I Goicoechea, M Armesto, M Arestin, ... Microrna 5 (2), 87-105, 2016 | 7 | 2016 |
Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous … I Goicoechea, R Rezola, M Arestin, MM Caffarel, AR Cortazar, ... F1000Research 6, 1606, 2018 | 3 | 2018 |
Expression of a truncated B lymphocyte-induced maturation protein-1 isoform is associated with an incomplete plasmacytic differentiation program in chronic lymphocytic leukemia C Solé, D Martínez, E Giné, B Gonzalez-Farre, P Pérez-Galán, ... Leukemia & Lymphoma 59 (2), 482-485, 2018 | 1 | 2018 |
Use of Gain-of-Function Screening to Identify miRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer S Nemours, C Solé, I Goicoechea, M Armesto, M Arestin, A Urruticoechea, ... International Journal of Molecular Sciences 25 (24), 13630, 2024 | | 2024 |